Silverarc Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.6M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.92M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.1M | Buy |
|
|||||
|
2023
Q3 | $728K | Buy |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $926K | Buy |
|
|||||
|
2022
Q4 | $87.6K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.33K | Buy |
|
|||||
|
2021
Q4 | $2.45M | Buy |
|
|||||
|
2021
Q3 | $1.75M | Buy |
|
|||||
|
2021
Q2 | $519 | Buy |
|
|||||
|
2021
Q1 | $461K | Buy |
|